Cambrex Corporation

Cambrex Corporation is a globally recognized pharmaceutical development and manufacturing company specializing in Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, analytical services, and process development. Founded in 1981 and headquartered in High Point, North Carolina, USA, Cambrex has become a trusted manufacturing partner for pharmaceutical and biotechnology companies worldwide. The company provides integrated solutions that support projects from preclinical development through commercial-scale manufacturing.

Cambrex’s core expertise includes custom API synthesis, small molecule development, solid-state chemistry, analytical testing, process optimization, and regulatory support. Its advanced manufacturing capabilities include highly potent APIs (HPAPIs), controlled substances, continuous manufacturing technologies, and specialized chemical processes. The company serves innovative pharmaceutical companies, generic manufacturers, and emerging biotechnology organizations across multiple therapeutic areas.

With manufacturing and research facilities located throughout North America and Europe, Cambrex follows rigorous international quality standards and maintains strong regulatory compliance with global health authorities. Continuous investment in technology, automation, sustainability, and scientific expertise enables Cambrex to deliver reliable, scalable manufacturing solutions. Through its commitment to innovation, operational excellence, and customer collaboration, Cambrex has established itself as one of the world’s leading API development and manufacturing organizations.